Fellowship · New York, NY
Sponsored by Zucker School of Medicine at Hofstra/Northwell
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Lancet (London, England) · 2024 · 251 citations · Isabel Preeshagul
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
Cancer discovery · 2022 · 155 citations · Morana Vojnic
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
Nature medicine · 2022 · 152 citations · Isabel Preeshagul
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis.
The lancet. Psychiatry · 2026 · 9 citations · Kelsey Martin
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review.
Cancers · 2024 · 38 citations · George Zacharia
Chemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics: A Systematic Review.
Neurology · 2025 · 19 citations ·
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2021 · 107 citations · Morana Vojnic
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.
Cancer discovery · 2025 · 19 citations · Morana Vojnic